FDFT1 Antibody (N-term) Blocking Peptide

FDFT1 Antibody (N-term) Blocking Peptide

€363.00
In stock
SKU
AC-BP2417a
Catalog Number: AC-BP2417a
Size: 500 µg
Datasheet
Request Information
Background:
FDFT1 catalyzes the first step in the cholesterol biosynthetic pathway, the conversion of trans-farnesyldiphosphate to squalene. The loss of promoter activity and response to sterols for FDFT1 is localized to a 69-bp section positioned 131 bp 5-prime to the transcription start site. Sequence analysis of this region shows that it contains a sterol regulatory element-1 (SRE1) previously identified in other sterol regulated genes and 2 putative NF1 binding sites.

Other Names:
Squalene synthase, SQS, SS, FPP:FPP farnesyltransferase, Farnesyl-diphosphate farnesyltransferase, FDFT1

Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP2417a was selected from the N-term region of human FDFT1 . A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.

Gene Name: FDFT1

Gene ID: 2222
Primary Accession: P37268
Other Accession: FDFT_HUMAN
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
More Information
Is Featured? No
Write Your Own Review
You're reviewing:FDFT1 Antibody (N-term) Blocking Peptide